Skip to main content

Table 1 Demographic data collected at the baseline

From: Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study

Variables Combined therapy group (n=32) Aspirin group (n=32) P
  Mean Std Mean Std  
Age (year) 62.7 6.4 64.4 6.5 0.338
Male Sex (%) 63.0% / 65.4% / 0.541
BMI (kg/m2) 24.71 3.12 24.03 3.28 0.442
SBP (mmHg) 142.56 15.92 149.05 15.41 0.138
DBP (mmHg) 74.90 8.04 77.94 7.48 0.160
HbA1C (%) 6.93 0.77 6.91 0.67 0.928
FBG (mmol/L) 6.99 2.76 6.62 1.67 0.556
CHOL (mmol/L) 5.12 0.85 5.21 0.91 0.722
TG (mmol/L) 1.52 0.68 2.02 1.47 0.118
HDL-C (mmol/L) 1.34 0.31 1.39 0.34 0.644
LDL-C (mmol/L) 3.09 0.76 2.91 0.95 0.446
AST (U/L) 20.74 4.43 27.88 16.11 0.031
ALT (U/L) 17.00 8.22 25.62 18.07 0.029
BUN (mmol/L) 6.96 1.87 6.53 1.89 0.407
CREA (μmol/L) 108.63 21.09 106.04 25.10 0.685
CCR (ml/min) 56.10 12.98 55.99 16.80 0.980
Medication use
 Antihypertensive drugs (%) 90.63 / 90.63 / 1.000
 Insulin (%) 68.75 / 65.63 / 0.790
 Statins (%) 15.63 / 18.75 / 0.740
  1. Plus-minus values are mean±S.D